Skip to main content

MoneyWorks4Me

A slight decline in the revenue of Rs. 179.34 millions was seen for the June 2022 quarter as against Rs. 187.41 millions during year-ago period.A slender decline of -23.06% was recorded to Rs. 10.01  millions from Rs. 13.01 millions in the corresponding previous quarter.A decline of 28.72 millions was observed in the OP in the quarter ended June 2022 from 30.12 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 179.34 187.41 -4.31 179.34 187.41 -4.31 694.30 560.15 23.95
Other Income 0.16 0.79 -79.75 0.16 0.79 -79.75 5.92 5.85 1.20
PBIDT 28.72 30.12 -4.65 28.72 30.12 -4.65 90.07 88.17 2.15
Interest 5.74 4.53 26.71 5.74 4.53 26.71 20.66 22.06 -6.35
PBDT 22.98 25.59 -10.20 22.98 25.59 -10.20 69.41 66.11 4.99
Depreciation 9.63 8.25 16.73 9.63 8.25 16.73 35.48 35.11 1.05
PBT 13.35 17.34 -23.01 13.35 17.34 -23.01 33.93 31.00 9.45
TAX 3.34 4.33 -22.86 3.34 4.33 -22.86 7.50 7.75 -3.23
Deferred Tax 0.41 0.74 -44.59 0.41 0.74 -44.59 3.05 2.46 23.98
PAT 10.01 13.01 -23.06 10.01 13.01 -23.06 26.43 23.25 13.68
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 16.01 16.07 -0.36 16.01 16.07 -0.36 12.97 15.74 -17.58
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..